# K060409: Hemohalt Hemostasis Pad

- Pathway: 510(k) (Traditional)
- Applicant: Vanson-Halosource, Inc.
- Decided: May 17, 2006 after 90 days
- Product code: QSY (Hemostatic Wound Dressing Without Thrombin Or Other Biologics)
- Device class: U
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 1 cites it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. The FDA summary names no predicate by number.

## Most influential descendants
- K120782: Interventional Hemostatic Bandage (2013), 1 descendant of its own
- K181641: QuikClot Radial (2018), 0 descendants of its own

## Indications for use
The HemoHalt Hemostasis Pad is intended for the local management and rapid control of bleeding (hemostasis): for skin surface puncture sites for vascular percutaneous catheters and/or tubes; following hemodialysis procedures, treatments; for patients on anticoagulation therapy; and for lacerations, abrasions, and nose bleeds. For use only on external bleeding wounds.

Source page: https://510kreport.com/device/K060409
Methodology: https://510kreport.com/methodology